Insights

A&M Newsletters
Comprehensive and timely perspectives, on the topics that matter to you, sent straight to your inbox.
Created

Launching an MGU in Today's Market

September 11, 2025
Explore what it takes to build a Managing General Underwriter (MGU) from the group up in our latest episode of Perspective First. Join host David Carey in conversation with Dan Grayzel, Head of Corporate Development and Strategy at Ascendex, as they discuss launching in today's competitive market and the strategies that drive success.
Thought Leadership

The Cyclicality of Real Estate: A Critical Lesson for Government Infrastructure

September 11, 2025
The Federal real estate has long operated out of sync with the natural boom-and-bust cycles that shape the commercial real estate market. With 11.4 million square feet of leases set to expire, the federal government has an incredible opportunity to realign it’s real estate holdings to the market.
Thought Leadership

Changes Coming to the Washington Sales Tax Landscape on October 1, 2025

September 11, 2025
In May 2025, Washington enacted multiple tax bills into law, including Senate Bill 5814 (SB 5814), which takes effect on October 1st and will broaden the sales and use tax base and the Business and Occupation (B&O) tax retailing classification to include several new services.

Griffin Coal

September 10, 2025
Griffin Coal - A&M AUS Insolvency Portal

Entyr Group

September 10, 2025
Entyr Group - A&M AUS Insolvency Portal
Thought Leadership

Private Equity Value Creation Report: Australia 2025

September 10, 2025
The Australian private equity market is set to play a pivotal role in shaping the country’s economic future. In our inaugural Australia Private Equity Value Creation report, we deep dive into how Australian-focused PE funds and operators are performing and how their strategies compare globally.
Thought Leadership

SWISS DEBT RESTRUCTURING MORATORIUM SURVEY 2024

September 9, 2025
Alvarez & Marsal's new Swiss Debt Restructuring Moratorium Survey reveals the number of cases peaked once again in 2024, building on the increased utilization already observed in 2023.
Thought Leadership

What if the biosimilar wave is just a ripple?

September 9, 2025
As biologics face a record-breaking patent cliff, the anticipated biosimilar wave may be more of a ripple than a wave. To thrive, life sciences firms must shift from solely pursuing speed to mastering precision.